Related Experiment Video

Updated: May 16, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

Does predicting positive nonsentinel nodes answer the question of axillary dissection and provide a benefit?

Carol Slomski, Thomas B Julian

    Journal of the National Cancer Institute
    |December 11, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
    07:51

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

    Published on: June 1, 2019

    Related Experiment Videos

    Last Updated: May 16, 2026

    Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
    11:49

    Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

    Published on: April 3, 2026

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
    07:51

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

    Published on: June 1, 2019

    Related Concept Videos

    Sensitivity, Specificity, and Predicted Value01:13

    Sensitivity, Specificity, and Predicted Value

    In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
    Sensitivity is the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and Axilla.

    Annals of surgical oncology·2026

    Lumpectomy Margins and Local Recurrence in DCIS: Results From the NRG Oncology/NSABP B-35 Randomized Clinical Trial.

    JAMA surgery·2026

    NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.

    Future oncology (London, England)·2025

    Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

    The New England journal of medicine·2025

    Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial.

    JAMA surgery·2025

    Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery.

    Journal of the National Cancer Institute·2024

    Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.

    Journal of the National Cancer Institute·2026

    Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation.

    Journal of the National Cancer Institute·2026

    A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

    Journal of the National Cancer Institute·2026

    Cancer rarity and mortality: Evidence from a nationwide cohort study.

    Journal of the National Cancer Institute·2026

    Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

    Journal of the National Cancer Institute·2026

    Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

    Journal of the National Cancer Institute·2026

    An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

    Neurological research·2026

    Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

    Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

    Endocrine-related cancer·2026

    Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    Anesthesiology·2026

    Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

    Cancer cytopathology·2026

    PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

    Pakistan journal of pharmaceutical sciences·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us